The safe-guarded researcher is being crowned the Canadian Science Talent Award

Elyssa newsroom
This scientific coronation came in recognition of her research on the use of AI technologies to discover targeted therapeutic compounds for diabetes.
The researcher's work focused on using artificial intelligence to accelerate the pathway of identification and development of new drugs and compounds for diabetes based on her laboratory research. Her victory is an international recognition of her scientific efforts at the Pasteur Institute in Tunis to develop innovative therapeutic solutions for this chronic disease.